Cyberounds Logo
May 19, 2019 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Road Traffic Injuries: A Global Epidemic
CME credit is no longer available for this conference.
Lauren P. Giles, B.A., Elisabeth S. Hayes, M.B.A., and Mark L. Rosenberg, M.D., M.P.P.

Dr. Rosenberg is Executive Director of the Task Force for Child Survival and Development. Ms. Giles and Ms. Hayes are, respectively, Program Development Coordinator and Senior Program Associate for the Global Road Safety Program at the Task Force. The Task Force for Child Survival and Development is an independent non-profit organization affiliated with Emory University, Atlanta, Georgia.

The authors report no commercial conflict of interest.


Release Date: 05/23/2005
Termination Date: 05/23/2008

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Describe the worldwide road safety epidemic in terms of its human and economic tolls, as well as its impact on global social equity
  • Describe the roles of the driver, vehicle and built environment in road safety
  • Define populations at high risk for road traffic injuries
  • Describe the major factors influencing road crash involvement and crash severity, and key interventions to reduce crash risk.

 
This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity